Published in Health Risk Factor Week, April 10th, 2007
"The single most important step towards the production of a cell-culture-based vaccine against a targeted virus is the ability to grow the same virus in a cell substrate. The announcement clearly demonstrates that not only are HepaLife's PBS-1 cells capable of replicating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.